Yves Levy

Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 195 publications

Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines.

Cross-Reactive Bundibugyo Antibody Responses after Receipt of Licensed Ebola Vaccines.

Journal: The New England journal of medicine

Published: July 22, 2026

Towards Elimination of Sexually Transmitted Infections: Research Developments and Vaccine Uptake.

Towards Elimination of Sexually Transmitted Infections: Research Developments and Vaccine Uptake.

Journal: Journal of the International AIDS Society

Published: July 03, 2026

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Journal: medRxiv : the preprint server for health sciences

Published: June 22, 2026

Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines.

Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines.

Journal: medRxiv : the preprint server for health sciences

Published: June 05, 2026

Dynamics of Circulating Follicular Helper and Regulatory T-Cell Memory Induced by mRNA, Inactivated, and Live-Attenuated Vaccines.

Dynamics of Circulating Follicular Helper and Regulatory T-Cell Memory Induced by mRNA, Inactivated, and Live-Attenuated Vaccines.

Journal: Journal of immunology research

Published: April 29, 2026

Comparison of Four Assays That Measure Antibodies to Ebola Virus Glycoprotein.

Comparison of Four Assays That Measure Antibodies to Ebola Virus Glycoprotein.

Journal: bioRxiv : the preprint server for biology

Published: March 27, 2026

SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients.

SARS-CoV-2 mRNA XBB1.5 vaccine immunogenicity in kidney transplant recipients.

Journal: Virology journal

Published: February 06, 2026

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

CD40.HIVEnv, an antibody mediated vaccine, induces long-term and recall immunogenicity in non-HIV-1 infected volunteers.

Journal: Scientific reports

Published: January 06, 2026

CD8+ stem cell-like memory T cells: Unveiling the potential for next-generation vaccination strategies.

CD8+ stem cell-like memory T cells: Unveiling the potential for next-generation vaccination strategies.

Journal: Cell reports. Medicine

Published: November 04, 2025

Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa.

Kinetics of anti-SARS-CoV-2 IgG in saliva and serum post infection, and subsequent vaccination in South Africa.

Journal: African journal of laboratory medicine

Published: October 08, 2025

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial.

Journal: PLoS neglected tropical diseases

Published: September 22, 2025

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Immunogenicity and protective efficacy on non-adjuvanted CD40-targeting SARS-CoV-2 vaccines in non-human primates.

Journal: EBioMedicine

Published: September 10, 2025

Showing 1-12 of 195

Last Updated: 09/26/2026